Synthesis and antibacterial activity of novel oxazolidinones with methylene oxygen- and methylene sulfur-linked substituents at C5-position

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 17, 2007, Pages 4778-4783

  Rudra, Sonali ^a   Sangita, Fnu ^a   Gujrati, Arti ^a   Pandya, Manisha ^a   Bhateja, Pragya ^a   Mathur, Tarun ^a   Singhal, Smita ^a   Rattan, Ashok ^a   Salman, Mohammed ^a   Das, Biswajit ^a  

^a Ranbaxy Laboratories Limited   (India)

Author keywords

Antibacterial; Nitro thiophene; Oxazolidinone; RBx 8700

Indexed keywords

CARBENE; OXAZOLIDINONE DERIVATIVE; OXYGEN; RBX 8700; SULFUR; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SCREENING; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; MASS SPECTROMETRY; METHICILLIN; MICROBIAL SENSITIVITY TESTS; MODELS, CHEMICAL; OXAZOLIDINONES; PIPERAZINES; SULFUR; TEMPERATURE; THIOCARBAMATES;

NEGIBACTERIA; POSIBACTERIA;

EID: 34547555955     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.06.056     Document Type: Article

References (24)

1. Brickner S.J., Hutchinson D.K., Barbachyn M.R., Manninen P.R., Ulanowicz D.A., Garmon S.A., Grega K.C., Hendges S.K., Toops D.S., Ford C.W., and Zurenko G.E. J. Med. Chem. 39 (1996) 673
2. Brickner S.J. Curr. Pharm. Des. 2 (1996) 175
3. Phillips O.A. Curr. Opin. Invest. Drugs 4 (2003) 117
4. Aoki H., Ke L., Poppe S.M., Poel T.J., Weaver E.A., Gadwood R.C., Thomas R.C., Shinabarger D.L., and Ganoza M.C. Antimicrob. Agents Chemother. 46 (2002) 1080 and references cited therein
5. Hutchinson D.K. Curr. Top. Med. Chem. 3 (2003) 1021
6. Barbachyn M.R., and Ford C.W. Angew. Chem. Int. Ed. 42 (2003) 2010
7. Tokuyama R., Takahashi Y., Tomita Y., Suzuki T., Yoshida T., Iwasaki N., Kado N., Okezaki E., and Nagato O. Chem. Pharm. Bull. 49 (2001) 347
8. Tokuyama R., Takahashi Y., Tomita Y., Tsubouchi M., Yoshida T., Iwasaki N., Kado N., Okezaki E., and Nagato O. Chem. Pharm. Bull. 49 (2001) 353
9. Tokuyama R., Takahashi Y., Tomita Y., Tsubouchi M., Yoshida T., Iwasaki N., Kado N., Okezaki E., and Nagato O. Chem. Pharm. Bull. 49 (2001) 361
10. Gravestock M.B., Acton D.G., Betts M.J., Dennis M., Hatter G., McGregor A., Swain M.C., Wilson R.G., Woods L., and Wookey A. Bioorg. Med. Chem. Lett. 13 (2003) 4179
11. Reck F., Zhou F., Girardot M., Kern G., Eyermann C.J., Hales N.J., Ramsar R.R., and Gravestock M.B. J. Med. Chem. 48 (2005) 499
12. Gravestock, M. B.; Roberts, D. A.; Betts, M. J.; Mills, S. D.; Hatter, G. PCT WO 00/21960, 2000.
13. Mehta, A.; Rudra, S.; Rajarao, A. V. S.; Yadav, A. S.; Rattan, A. PCT WO 04/014392, 2004.
14. Sood R., Bhaduria T., Rao M., Gautam R., Malhotra S., Barman T.K., Upadhyay D., and Rattan A. Infect. Disord. Drug Targets 6 (2006) 343
15. Sood R., Rao M., Singhal S., and Rattan A. Int. J. Antimicrob. Agents 25 (2005) 464
16. Rao M., Sood R., Malhotra S., Fatma T., Upadhyay D.J., and Rattan A. J. Chemother. 18 (2006) 144
17. Mehta, A.; Das, B.; Rudra, S.; Yadav, A.; Sangita, Salman, M.; Rattan, A. PCT WO 06/043121, 2006.
18. Hutchinson, D. K.; Brickner, S. J.; Gammill, R. V.; Patel, M. V. U.S. Patent 5700799, 1997.
19. 2).
20. 2 incubator was used for incubation. Zone of inhibition sizes were measured using vernier caliper.
21. 2 atmosphere at 35 °C for 18-24 h.
22. log P values were calculated using Advanced Chemistry Development Software V 9.14.
23. Paget S.D., Boggs C.M., Foleno B.D., Goldschmidt R.M., Hlasta D.J., Weidner-Wells M.A., Werblood H.M., Bush K., and Macielag M.J. Bioorg. Med. Chem. Lett. 16 (2006) 4537
24. Jang S.-Y., Ha Y.H., Ko S.W., Lee W., Lee J., Kim S., Kim Y.W., Lee W.K., and Ha H.-J. Bioorg. Med. Chem. Lett. 14 (2004) 3881